Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2006 2
2007 1
2008 1
2009 4
2011 3
2013 5
2014 4
2015 2
2016 5
2017 6
2018 7
2019 5
2020 9
2021 6
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Results by year
Filters applied: . Clear all
Page 1
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency.
Miravitlles M, Dirksen A, Ferrarotti I, Koblizek V, Lange P, Mahadeva R, McElvaney NG, Parr D, Piitulainen E, Roche N, Stolk J, Thabut G, Turner A, Vogelmeier C, Stockley RA. Miravitlles M, et al. Among authors: koblizek v. Eur Respir J. 2017 Nov 30;50(5):1700610. doi: 10.1183/13993003.00610-2017. Print 2017 Nov. Eur Respir J. 2017. PMID: 29191952 Free article. Review.
Optimizing clinical approaches to COVID-19 patients in primary care.
Seifert B, Balík M, Bártů V, Bezdíčková L, Černý V, Čierná-Peterová I, Čupka J, Dlouhý P, Halata D, Karen I, Kessler P, Koblížek V, Král N, Kvasnička T, Kvasnička J, Mucha C, Penka M, Svačina Š, Šeblová J, Špaček M, Trojánek M. Seifert B, et al. Among authors: koblizek v. Cas Lek Cesk. 2021 Summer;160(4):119-125. Cas Lek Cesk. 2021. PMID: 34416813 English.
Use of mucolytics in COPD: A Delphi consensus study.
Papi A, Avdeev S, Calverley PMA, Cordeiro CR, Jesenak M, Koblížek V, Petkova D, Rogliani P, Tarraf H, Tzanakis N, Ulmeanu R, Uzaslan E, Adir Y. Papi A, et al. Among authors: koblizek v. Respir Med. 2020 Dec;175:106190. doi: 10.1016/j.rmed.2020.106190. Epub 2020 Nov 13. Respir Med. 2020. PMID: 33217537
Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.
Miravitlles M, Roche N, Cardoso J, Halpin D, Aisanov Z, Kankaanranta H, Kobližek V, Śliwiński P, Bjermer L, Tamm M, Blasi F, Vogelmeier CF. Miravitlles M, et al. Among authors: koblizek v. Respir Res. 2018 Jan 18;19(1):11. doi: 10.1186/s12931-018-0715-1. Respir Res. 2018. PMID: 29347928 Free PMC article. Review.
Chronic obstructive pulmonary disease: diagnosis and treatment of stable phase of disease; personalized treatment approach using phenotype features of the disease Summary of the 2020-2021 Czech Pneumological and Phthiseological Society position paper.
Brat K, Zatloukal J, Neumannová K, Voláková E, Kudela O, Kopecký M, Plutinský M, Koblížek V. Brat K, et al. Among authors: koblizek v. Vnitr Lek. 2021 Summer;67(4):230-239. Vnitr Lek. 2021. PMID: 34275309 Review. English.
Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.
Ariel A, Altraja A, Belevskiy A, Boros PW, Danila E, Fležar M, Koblizek V, Fridlender ZG, Kostov K, Krams A, Milenkovic B, Somfay A, Tkacova R, Tudoric N, Ulmeanu R, Valipour A. Ariel A, et al. Among authors: koblizek v. Int J Chron Obstruct Pulmon Dis. 2017 Dec 21;13:45-56. doi: 10.2147/COPD.S145573. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29317810 Free PMC article. Review.
Introducing a new prognostic instrument for long-term mortality prediction in COPD patients: the CADOT index.
Brat K, Svoboda M, Hejduk K, Plutinsky M, Zatloukal J, Volakova E, Popelkova P, Novotna B, Engova D, Franssen FME, Vanfleteren LEGW, Spruit MA, Koblizek V. Brat K, et al. Among authors: koblizek v. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Jun;165(2):139-145. doi: 10.5507/bp.2020.035. Epub 2020 Sep 10. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021. PMID: 32955038 Free article.
61 results